
National / Science & Health Oct 26, 2017
Venture behind worm cancer-screening method raises ¥30 million from Shinkin Capital
by Tomoko Otake
Hirotsu Bio Science, a medical venture developing a cancer screening tool using nematodes, has secured ¥30 million in funding from Shinkin Capital Co. to accelerate growth in overseas markets, the firm announced Thursday. The Tokyo-based venture run by Takaaki Hirotsu, formerly a biology researcher at ...